An Overview of Off-Label Use of Humanized Monoclonal Antibodies in Paediatrics

An Overview of Off-Label Use of Humanized Monoclonal Antibodies in Paediatrics

In recent years, off-label and unlicensed drug use has extensively developed in the paediatric population. For a long time, clinical trials in the paediatric population were considered complicated to perform because of ethical problems, causing frequent off-label use. Off-label drug use remains an i...

Full description

Bibliographic Details
Main Authors: Roberto Bernardini, Gaia Toschi Vespasiani, Arianna Giannetti
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Medicina
Subjects:
off-label
humanized monoclonal antibodies
paediatrics
children
omalizumab
mepolizumab
Online Access:https://www.mdpi.com/1648-9144/58/5/625

Similar Items

Similar Items